David Shaw’s Loxo Oncology, Inc LOXO Stock Holding History

David Shaw’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-19,434	Closed	-$818K	–	3638
2017 Q1	$818K	Sell	19,434 -27,742	-59%	-$1.14M	﹤0.01%	2441
2016 Q4	$1.51M	Buy	+47,176	New	+$1.21M	﹤0.01%	2203

Other funds holding LOXO

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

David Shaw's LOXO Position: Q2 2017 in Review

David Shaw sold out of Loxo Oncology, Inc (LOXO) in Q2 2017, closing a stake of 19,434 shares — an estimated $818K sold.

David Shaw first reported a position in LOXO in Q4 2016 and held it in 2 quarters. The position peaked at $1.51M in Q4 2016. 129 funds tracked by Wall St. Rank hold LOXO as of Q2 2017.

David Shaw reported no remaining Loxo Oncology, Inc position as of Q2 2017 after selling out during the quarter.
David Shaw sold 19,434 Loxo Oncology, Inc shares in Q2 2017, an estimated $818K.
David Shaw first reported a position in Loxo Oncology, Inc in Q4 2016 and held it in 2 quarters.
David Shaw's Loxo Oncology, Inc position peaked at $1.51M in Q4 2016.
129 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q2 2017.

Based on D.E. Shaw & Co's 13F filing for Q2 2017, filed 14 Aug 2017.